|Articles|September 3, 2019
Harbour BioMed Leverages PPD’s Biotech to Develop Innovative Therapeutics
Advertisement
Harbour BioMed and Pharmaceutical Product Development, LLC have announced that HBM will use the services of PPD’s Biotech to develop innovative therapeutics in the areas of oncology and immunology.
To learn more, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5